ArticleCureus2026
Central Retinal Vein Occlusion in a Young Healthy Man Following Strenuous Exercise: Multimodal Imaging and Treatment Response.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Central retinal vein occlusion (CRVO) is uncommon in young, otherwise healthy individuals and is often associated with underlying systemic or hematological risk factors. We report a case of a 23-year-old healthy man who presented with sudden painless diminution of vision in the right eye shortly after engaging in strenuous physical exercise involving heavy weightlifting. Best-corrected visual acuity at presentation was 6/18. Fundus examination revealed optic disc edema, dilated and tortuous retinal veins, and widespread intraretinal hemorrhages consistent with non-ischemic CRVO. Optical coherence tomography (OCT) demonstrated significant cystoid macular edema with a central macular thickness of 823 µm and associated subretinal fluid. Comprehensive systemic evaluation, including hematological, metabolic, coagulation, autoimmune, cardiac, and carotid workup, was unremarkable. The patient was treated with intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy, resulting in marked anatomical improvement and visual recovery to 6/9 on follow-up. Although CRVO in young patients is rare and often idiopathic, intense physical exertion may act as a potential precipitating factor through transient hemodynamic changes such as increased venous pressure, Valsalva-like mechanisms, and hemoconcentration. This case highlights the importance of considering recent physical stressors in the clinical history and demonstrates a favorable treatment response with anti-VEGF therapy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.